Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Stock Movers: Synaptics, Lumentum, Acadia Pharma
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street. Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for…
A Big Pharma Executive Is Jumping to Nike-and Critics Are Already Questioning the Move
A sportswear giant is making key leadership changes. Nike recently announced that Pfizer executive David Denton will take over as its chief financial officer later this summer. The news comes shortly after Pfizer announced Denton would be stepping…
Indian Pharma Bets Beyond US Generics
Companies are investing heavily in complex injectables, respiratory therapies and biosimilars to improve margins and diversify portfolios. Indian pharmaceutical companies are increasingly shifting their growth focus beyond the traditional US…
'Spurious' injections that 'contained no oxytocin': Rajasthan pharma distributor loses licence
Rajasthan's Drug Control Department has cancelled the wholesale drug licence of a pharma distributor operating out of Kota over the alleged sale of thousands of spurious oxytocin injections and other irregularities. The action comes amid heightened…
Why Is Shuttle Pharma Stock Gaining Friday? - Shuttle Pharmaceuticals (NASDAQ:SHPH)
The company said it is assessing behind-the-meter power generation assets in Idaho and Alberta as part of a strategy aimed at lowering operating costs and increasing flexibility for its growing mining business. United Dogecoin said the initiative…
Government proposes simplified drug import rules to boost pharma R&D
In a significant step towards promoting research and innovation and enhancing ease of doing business in the pharmaceutical sector, the Union Ministry of Health and Family Welfare has proposed amendments to the Drugs Rules, 1945, to simplify the…
Alembic Pharma gets USFDA final approval for Oseltamivir oral suspension
Alembic Pharmaceuticals has received final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Oseltamivir Phosphate for Oral Suspension, 6 mg/mL. The approved ANDA is therapeutically…
Zydus Lifesciences, Sunshine Healthcare form $20 million JV to set up pharma manufacturing facility in Sri Lanka
Zydus Lifesciences and Sri Lanka's Sunshine Healthcare have formed a joint venture to establish a pharmaceutical manufacturing facility in Sri Lanka with an investment commitment of over $20 million, as the island nation looks to strengthen…
Latest LPG supply directives and what changes now | Explained
The story so far: In the first signs of easing pressure on liquified petroleum gas (LPG) with the probable culmination of the West Asia conflict, the Union Petroleum Ministry Thursday (June 25, 2026) restored commercial LPG supply to the pre-crisis…
Novo Nordisk: 3 Key Reasons The 'Buy The Dip' Thesis Is Flawed (NYSE:NVO)
Novo Nordisk A/S faces a complex outlook as GLP-1 market leadership is challenged by intensifying competition and pricing pressures. NVO's 2026 guidance forecasts a 4–12% decline in revenues and operating profit, driven by lower realized…
A Breakthrough-Designated Depression Drug Is 86% Through Its Phase 3, With Topline Data Due This Year
Issued on behalf of Helus Pharma™ Helus Pharma™ (NASDAQ: HELP) (Cboe CA: HELP), the commercial operating name of Cybin Inc., says its APPROACH Phase 3 trial of HLP003 for adjunctive treatment of major depressive disorder has surpassed…
Help reimagine health care for Oregonians and all
As America prepares to celebrate our 250th anniversary, a more recent but disturbing anniversary looms large for millions of families in Oregon and nationwide. On July 4th, 2025, congressional Republicans passed their so-called One, Big, Beautiful…
Snap's Specs Gamble
In this episode of Motley Fool Hidden Gems Investing, Motley Fool contributors Travis Hoium, Lou Whiteman, and Rachel Warren discuss: Snap's new Specs. Rivian announces more layoffs. Eli Lilly's acquisition spree continues. To catch full episodes…
British American Tobacco Stock: Not Simply Philip Morris' Lagging Sibling (NYSE:BTI)
British American Tobacco is rated as a Sell due to unclear growth in its Vapour and Heated Product segments, margin dilution, and regulatory headwinds despite a ~5.4% dividend yield. BTI's Modern Oral segment has shown strong growth and is…
Dyne Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
High-stakes clinical trials define the 2026 landscape for Dyne Therapeutics (DYN +4.34%) and Viking Therapeutics (VKTX +3.79%). Both firms seek to revolutionize patient care while navigating the complex path toward regulatory approval. Dyne targets…
Receive a Daily briefing on Pharma Industry News
Get Started